Skip to main content
Clinical Trials/NCT06760286
NCT06760286
Completed
Not Applicable

Breathe-Easy Study: A Community-Based Trial on the Efficacy of Lung Care Solution for Improving Lung Capacity and Symptom Relief in Respiratory Conditions

Innowage Limited1 site in 1 country78 target enrollmentMay 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiration Disorders
Sponsor
Innowage Limited
Enrollment
78
Locations
1
Primary Endpoint
Changes in pulmonary function
Status
Completed
Last Updated
last year

Overview

Brief Summary

The trial aims to assess the effectiveness of a natural lung care solution and a food supplement in improving lung function, capacity, and alleviating symptoms associated with respiratory conditions like asthma, COPD, and chronic bronchitis.

Registry
clinicaltrials.gov
Start Date
May 12, 2024
End Date
November 12, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 and older.
  • Diagnosed with a chronic respiratory condition (e.g., asthma, COPD).
  • No known allergies to ingredients in the supplement.
  • Ability to provide informed consent and comply with study procedures.

Exclusion Criteria

  • Acute respiratory infection within the last 30 days.
  • Current participation in another clinical trial.
  • History of severe adverse reactions to similar supplements.

Outcomes

Primary Outcomes

Changes in pulmonary function

Time Frame: Change in forced expiratory volume (FEV1) from baseline to 12 weeks.

Differences in forced expiratory volume measured by spirometry

Secondary Outcomes

  • Symptom Severity Scores(Change in symptom scores from baseline to 12 weeks.)
  • Quality of Life (QoL)(Change in quality of life from baseline to 12 weeks.)

Study Sites (1)

Loading locations...

Similar Trials